The Legal 500

SOTERA HEALTH COMPANY (NASDAQ: SHC) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Sotera Health Company (NASDAQ: SHC)

Retrieved on: 
Monday, January 30, 2023
GTCR, Health, Safety, Culture, Goldman Sachs, JPMorgan Chase, Ethylene oxide, The Legal 500, Advertising, Offerings, Cancer, LLP, Atmosphere, Risk, Court, EPA, Sterilization, SPO, Class, Labour government, IPO, NATA, Warburg Pincus, District court, Probability, Investment, Pressure, News, Tobacco, Security (finance), Oil, Sotera Tschetter, Nordion

NEW YORK, Jan. 30, 2023 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Sotera Health Company (“Sotera” or the “Company”) common stock: (i) pursuant and/or traceable to the Company’s initial public offering conducted on or around November 20, 2020 (the “IPO”); (ii) pursuant and/or traceable to the Company’s secondary public offering conducted on or around March 18, 2021 (the “SPO,” and together with the IPO, the “Offerings”); and/or (iii) between November 20, 2020 and September 19, 2022, inclusive (the “Class Period”). The lawsuit was filed in the United States District Court for the Northern District of Ohio and alleges violations of the Securities Act of 1933 and the Securities Exchange Act of 1934.

Key Points: 
  • If so, please visit Sotera Health Company Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or [email protected] to discuss your rights.
  • The Company’s sterilization services rely on three primary technologies, one of which is Ethylene Oxide (“EtO”) processing.
  • Sotera, through its Sterigenics business, conducts or has conducted EtO processing at facilities located in Illinois, California, Georgia, and New Mexico.
  • The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414.

Y-MABS THERAPEUTICS, INC. (NASDAQ: YMAB) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB)

Retrieved on: 
Thursday, January 26, 2023
Marketing, RTF, Food, Food and Drug Administration, CNS, The Legal 500, Advertising, Cancer, Bias, Court, Therapy, Survival, Advisory Committee, Labour government, Patient, FDA, District court, Investment, Aerospace, Letter, News, Tobacco, Pharmaceutical industry, Security (finance)

NEW YORK, Jan. 26, 2023 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the common stock of Y-mAbs Therapeutics, Inc. (“Y-mAbs” or the “Company”) (NASDAQ: YMAB) between October 6, 2020 and October 28, 2022, inclusive (the “Class Period”). The lawsuit was filed in the United States District Court for the Southern District of New York and alleges violations of the Securities Exchange Act of 1934.

Key Points: 
  • Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or [email protected] to discuss your rights.
  • The lawsuit was filed in the United States District Court for the Southern District of New York and alleges violations of the Securities Exchange Act of 1934.
  • Y-mAbs is a clinical-stage biopharmaceutical company focused on developing antibody therapeutics and medicines for the treatment of cancer patients of all ages.
  • The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414.

BIOVENTUS INC. (NASDAQ: BVS) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Bioventus Inc. (NASDAQ: BVS)

Retrieved on: 
Tuesday, January 24, 2023
The Legal 500, Advertising, LLP, Risk, Court, News, Class, Register, Labour government, IPO, Defendant, District court, Registration statement, Investment, Prospectus, Form 10-Q, Tobacco, Security (finance), Health insurance

NEW YORK, Jan. 24, 2023 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired: (a) Bioventus Inc. (“Bioventus”) Class A common stock pursuant and/or traceable to the Offering Documents issued in connection with the Company's initial public offering conducted on or about February 11, 2021 (the “IPO” or “Offering”); and/or (b) Bioventus securities between February 11, 2021 and November 21, 2022, both dates inclusive (the “Class Period”). The lawsuit was filed in the United States District Court for the Middle District of North Carolina and alleges violations of the Securities Act of 1933 and the Securities Exchange Act of 1934.

Key Points: 
  • Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or [email protected] to discuss your rights.
  • Bioventus is a medical device company that focuses on developing and commercializing clinical treatments to engage and enhance the body's natural healing process.
  • On January 20, 2021, Bioventus filed a registration statement with the SEC on February 10, 2021 (the “Registration Statement”).
  • The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414.

CAPITAL ONE FINANCIAL CORPORATION (NYSE: COF) INVESTIGATION ALERT: Bernstein Liebhard is investigating Capital One Financial Corporation

Retrieved on: 
Monday, January 23, 2023
Capital One, NYSE, The Legal 500, Advertising, LLP, Labour government, COF, Security (finance)

NEW YORK, Jan. 23, 2023 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, is investigating whether members of the Board of Directors of Capital One Financial Corporation (“Capital One”) (NYSE: COF) breached their fiduciary duties to Capital One.

Key Points: 
  • If so, please visit Capital One Financial Corporation Shareholder Investigation or contact Peter Allocco at (212) 951-2030 or [email protected] to discuss your rights.
  • NEW YORK, Jan. 23, 2023 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, is investigating whether members of the Board of Directors of Capital One Financial Corporation (“Capital One”) (NYSE: COF) breached their fiduciary duties to Capital One.
  • If you hold Capital One stock and would like to discuss your legal rights and options, please visit Capital One Financial Corporation Shareholder Investigation or contact Peter Allocco at (212) 951-2030 or [email protected] .
  • The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414.

SOUTHWEST AIRLINES CO. (NYSE: LUV) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Southwest Airlines Co. (NYSE: LUV)

Retrieved on: 
Monday, January 23, 2023
Access Now, Inc. v. Southwest Airlines Co., Federation, Rail transport by country, Software, Weather, NYSE, The Legal 500, Reuters, Travel, Advertising, Information, Court, Business Insider, Class, The New York Times, Labour government, Holiday, District court, Airport, Transport, Investment, Government, News, Airline, Southwest Airlines

NEW YORK, Jan. 23, 2023 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the securities of Southwest Airlines Co. (“Southwest” or the “Company”) (NYSE: LUV) between June 13, 2020 and December 31, 2022, inclusive (the “Class Period”). The lawsuit was filed in the United States District Court for the Southern District of Texas and alleges violations of the Securities Exchange Act of 1934.

Key Points: 
  • Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or [email protected] to discuss your rights.
  • Winter storms disrupted holiday travel during the 2022 holiday season, leaving thousands of travelers stranded in airports around the United States.
  • If you purchased or acquired Southwest Airlines securities, and/or would like to discuss your legal rights and options please visit Southwest Airlines Co.
  • The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414.

ENOVIX CORPORATION (NASDAQ: ENVX) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Enovix Corporation (NASDAQ: ENVX)

Retrieved on: 
Monday, January 23, 2023
Electronics, R, The Legal 500, Advertising, Acquisition, Cybook Gen1, Court, Labour government, District court, Investment, Letter, News, Mobile phone, Security (finance)

NEW YORK, Jan. 23, 2023 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the common stock of Enovix Corporation (“Enovix” or the “Company”) (NASDAQ: ENVX) between February 22, 2021 and January 3, 2023, inclusive (the “Class Period”), or Rodgers Silicon Valley Acquisition Corp. (“RSVAC”) common stock prior to July 15, 2021. The lawsuit was filed in the United States District Court for the Northern District of California and alleges violations of the Securities Exchange Act of 1934.

Key Points: 
  • If so, please visit Enovix Corporation Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or [email protected] to discuss your rights.
  • Five months after this announcement, on July 15, 2021, Enovix became a publicly traded company.
  • On July 14, 2021, Enovix was officially acquired by RSVAC, which then changed its name to Enovix Corporation.
  • The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414.

AVAYA HOLDINGS CORP. (NYSE: AVYA) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Avaya Holdings Corp. (NYSE: AVYA)

Retrieved on: 
Monday, January 23, 2023
COSO, Communication, Software, NYSE, The Legal 500, Advertising, Court, News, Kleffman v. Vonage Holdings Corp., EBITDA, Audit committee, Labour government, District court, Report, Investment, Ethics, Form, Committee, AVYA, Committee of Sponsoring Organizations of the Treadway Commission, Annual report, Security (finance), Property management, Renewable energy, Avaya

NEW YORK, Jan. 23, 2023 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the securities of Avaya Holdings Corp. (“Avaya” or the “Company”) (NYSE: AVYA) between November 22, 2021 and November 29, 2022, inclusive (the “Class Period”). The lawsuit was filed in the United States District Court for the Middle District of North Carolina and alleges violations of the Securities Exchange Act of 1934.

Key Points: 
  • Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or [email protected] to discuss your rights.
  • The lawsuit was filed in the United States District Court for the Middle District of North Carolina and alleges violations of the Securities Exchange Act of 1934.
  • If you purchased or acquired Avaya securities, and/or would like to discuss your legal rights and options please visit Avaya Holdings Corp.
  • The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414.

GAOTU TECHEDU INC. (NYSE: GOTU) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Gaotu Techedu Inc. f/k/a GSX Techedu Inc.

Retrieved on: 
Monday, January 23, 2023
Investment Technology Group, Policy, K-12, GOTU, GSX, NYSE, The Legal 500, Reuters, Advertising, Financial Times, Court, News, GSX Techedu, Sale, Labour government, District court, Investment, Organization, New Oriental, Tobacco, Tutoring, Security (finance), Great Architect of the Universe

NEW YORK, Jan. 23, 2023 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the American Depositary Shares (“ADSs”) of Gaotu Techedu Inc. f/k/a GSX Techedu Inc. (“Gaotu” or the “Company”) (NYSE: GOTU, GSX) between March 5, 2021 and July 23, 2021, inclusive (the “Class Period”). The lawsuit was filed in the United States District Court for the Eastern District of New York and alleges violations of the Securities Exchange Act of 1934.

Key Points: 
  • Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or [email protected] to discuss your rights.
  • Gaotu purports to be a technology-driven education company, providing online K-12 after-school tutoring services in the People’s Republic of China.
  • If you purchased Gaotu ADSs, and/or would like to discuss your legal rights and options please visit Gaotu Techedu Inc.
  • The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414.

DAKTRONICS, INC. (NASDAQ: DAKT) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Daktronics, Inc. (NASDAQ: DAKT)

Retrieved on: 
Monday, January 23, 2023
Tax, The Legal 500, Advertising, Court, News, Labour government, Transport, Disclosure, District court, Investment, Tobacco, Security (finance), Daktronics

NEW YORK, Jan. 23, 2023 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the securities of Daktronics, Inc. (“Daktronics” or the “Company”) (NASDAQ: DAKT) between March 10, 2022 and December 6, 2022, inclusive (the “Class Period”). The lawsuit was filed in the United States District Court for the Southern District of New York and alleges violations of the Securities Exchange Act of 1934.

Key Points: 
  • Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or [email protected] to discuss your rights.
  • Daktronics designs and manufactures electronic scoreboards, programmable display systems, and large screen video displays for sporting, commercial, and transportation applications.
  • Plaintiff alleges that Defendants made materially false and misleading statements, and omitted material facts, throughout the Class Period.
  • The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414.

TWIST BIOSCIENCE CORPORATION (NASDAQ: TWST) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Twist Bioscience Corporation (NASDAQ: TWST)

Retrieved on: 
Monday, January 23, 2023
DNA, Charles Ponzi, Biotechnology, The Legal 500, Advertising, Hospital, Court, Public expenditure, Labour government, Defendant, District court, Scorpion, Investment, Growth, Fraud, News, Tobacco, Renewable energy, Private investigator, Security (finance)

NEW YORK, Jan. 23, 2023 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the common stock of Twist Bioscience Corporation (“Twist” or the “Company”) (NASDAQ: TWST) between December 13, 2019 and November 14, 2022, inclusive (the “Class Period”). The lawsuit was filed in the United States District Court for the Northern District of California and alleges violations of the Securities Exchange Act of 1934.

Key Points: 
  • If so, please visit Twist Bioscience Corporation Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or [email protected] to discuss your rights.
  • The lawsuit was filed in the United States District Court for the Northern District of California and alleges violations of the Securities Exchange Act of 1934.
  • A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
  • The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414.